{"version":"1.0","provider_name":"Aescap","provider_url":"https:\/\/www.aescap.com\/nl\/","author_name":"Victor Bakker","author_url":"https:\/\/www.aescap.com\/nl\/author\/victorbakker\/","title":"Intra-Cellular Therapeutics overgenomen door Johnson & Johnson - Aescap","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"z57GdOR5Tn\"><a href=\"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/\">Intra-Cellular Therapeutics overgenomen door Johnson &#038; Johnson<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.aescap.com\/nl\/intra-cellular-therapeutics-overgenomen-door-johnson-johnson\/embed\/#?secret=z57GdOR5Tn\" width=\"600\" height=\"338\" title=\"&#8220;Intra-Cellular Therapeutics overgenomen door Johnson &#038; Johnson&#8221; &#8212; Aescap\" data-secret=\"z57GdOR5Tn\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.aescap.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Johnson &amp; Johnson neemt Intra-Cellular Therapeutics over, een bedrijf uit onze portfolio dat zich richt op innovatieve behandelingen voor neurologische aandoeningen. De overname bevestigt de waarde van onze selectiemethodiek en levert een aantrekkelijk rendement op voor onze beleggers. Vandaag kondigde Johnson &amp; Johnson (J&amp;J) de overname aan van Intra-Cellular Therapeutics. J&amp;J neemt dit Aescap Life [&hellip;]"}